The Latest
-
US$59.83 – That’s What Analysts Think Moderna, Inc. (NASDAQ:MRNA) Is Worth After These Results
-
Musk Emerges as Loudest Reopen Proponent With Tesla Threats
-
Bristol-Myers Squibb Company (NYSE:BMY) Just Reported, And Analysts Assigned A US$65.94 Price Target
-
BA owner says burning cash, quarantine plan will make it worse